Skip to content
December 8, 2014

Carefusion, Medacist Partner To Reduce Drug Diversion

CareFusion (NYSE:CFN), a leading global medical technology company, and Medacist Solutions Group, LLC (Medacist), the leader in drug diversion software analytics, today announced an agreement to collaborate to detect and deter drug diversion.

Under the agreement, CareFusion customers who use the company’s Knowledge Portal for Dispensing will be able to run the full version of RxAuditor diversion software. RxAuditor is recognized as the leading
medication diversion software in the industry.

“Our collaboration with Medacist brings together two leaders in medication safety that are dedicated to help hospitals detect and deter drug diversion,” said Rusty Frantz, senior vice president and general manager of Dispensing Technologies for CareFusion. “This collaboration fits well with our data and analytics strategy to take medication usage intelligence and bring additional insight and value to customers.

RxAuditor software is the only United States patented methodology that evaluates key metrics such as controlled substance dispenses, controlled substance discrepancies, medication overrides, waste transactions, cancelled transactions, stock-outs, refills and inventory shrinkage. The reports identify individuals who dispense medication outside of statistically significant parameters of all other users on a
hospital’s or integrated delivery network’s automated dispensing cabinets. These easy-to-use and accurate reports include assurance metrics that enable pharmacy managers to make an informed decision regarding internal audits to confirm or rule-out potential diversion.

“The integration of these two ‘best of class’ leaders with the shared goal of delivering collective expertise to the mutual clients we serve, will ensure a safe environment for the patients they serve, said David Brzozowski, Sr., President of Medacist Solutions Group. “We look forward to bringing our technology to all current and future Pyxis clients.”

Carefusion, Medacist Partner

In the News

View All Posts